METTL1 and hepatocellular carcinoma: It has been shown that the oncogenic function of METTLl can promote tumor cell proliferation and migration by inhibiting the PTEN-related signaling pathway, and that inhibition of METTL1/WDR4 activity reduces m7G tRNA modification and slows down the progression of hepatocellular carcinoma (18).